S 5265 · 119th Congress
A bill to identify and take action against international trade practices of high income countries that unfairly exploit innovation by deviating from market-based policies and unfairly exploit United States innovation, and for other purposes.
This bill creates a new position called the Chief Pharmaceutical Trade Negotiator within the U.S. Trade Representative's office to focus specifically on pharmaceutical trade issues. The main goal is to combat what Congress sees as unfair drug pricing practices by wealthy foreign countries that artificially keep medi…
- Sponsor
- Sheehy, Tim (R-Montana)
- Introduced
- 2026-08-05
- Policy area
- Foreign Trade and International Finance
- Latest action
- Read twice and referred to the Committee on Finance.
Digging through Congress... 🔍